Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission
Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
[LIVRE][B] Global hepatitis report 2017
World Health Organization - 2017 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
Approved antiviral drugs over the past 50 years
E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …
categorized into 13 functional groups have been formally approved for the treatment of the …
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions
Hepatitis B reactivation associated with immune-suppressive and biological therapies is
emerging to be an important cause of morbidity and mortality in patients with current or prior …
emerging to be an important cause of morbidity and mortality in patients with current or prior …
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
Background In 2016, of the estimated 257 million people living with chronic hepatitis B virus
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
EASL clinical practice guidelines: autoimmune hepatitis
European Association for the Study of The Liver - Journal of hepatology, 2015 - Elsevier
Autoimmune hepatitis (AIH) was the first liver disease for which an effective therapeutic
intervention, corticosteroid treatment, was convincingly demonstrated in controlled clinical …
intervention, corticosteroid treatment, was convincingly demonstrated in controlled clinical …